A Global Perspective: PARP Inhibitors in the Treatment of Metastatic Breast Cancer

Get up to date with international insights on assessing and targeting BRCA1/2 and other DNA damage repair gene alterations in metastatic breast cancer with downloadable slides from a video roundtable plus an expert commentary.

Share

Program Content

Activities

PARPi in Breast Cancer
How I Currently Use PARP Inhibitors to Improve Patient Outcomes in Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2020

Expires: September 21, 2021

Activities

PARPi in MBC
A Global Perspective: PARP Inhibitors in the Treatment of Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 24, 2020

Expires: November 23, 2021

Activities

PARPi in MBC
A Global Perspective: An Expert Roundtable on PARP Inhibitors in the Treatment of Metastatic Breast Cancer
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Pierfranco Conte, MD

Professor
DiSCOG
University of Padua
Padua, Italy
Director
U.O.C. Oncology 2
Istituto Oncologico Veneto, IOV - IRCSS
Padova, Italy

cover img faculity

Véronique Diéras, MD

Head, Breast Group
Medical Oncology Department
Centre Eugene Marquis UNICANCER
Rennes, France

cover img faculity

Mark E. Robson, MD

Chief, Breast Medicine Service
Attending Physician
Clinical Genetics and Breast Medicine Services
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca